Cotellic 20 mg, 63 tablets (Cobimetinib 20 mg per tablet) by Roche.
Indications: Unresectable or metastatic melanoma with BRAF V600 mutation, in combination with vemurafenib.
Administration: Oral: 60 mg once daily for 21 days followed by 7 days off (28-day cycle).
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Roche |
| Active ingredient | Cobimetinib 20 mg per tablet — MEK inhibitor. |
| Strength & pack | 63 film-coated tablets. |
| Form | Film-coated tablets |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |